If not, please take a few moments to fill out the form below. It’s free, and ensures that you receive regular alerts to the latest clinical news and other content.

Email*

Password*

Keep me logged in Forgot your password?

Email*

Brachytherapy

Perineural Invasion Predicts PSA Relapse After Brachytherapy

Jody A. Charnow April 16, 2012

Perineural invasion (PNI) and post-treatment PSA levels at 12 months strongly predict long-term PSA relapse-free survival (PRFS) after definitive brachytherapy seed implantation for prostate cancer (PCa), according to a study.

The Case for Brachytherapy: An Interview with Michael F. Sarosdy, MD

Delicia Honen Yard March 14, 2012

Having performed more than 1,200 brachytherapy treatments since 1996 and conducting research in this field, urologic oncologist Michael F. Sarosdy, MD, founder of South Texas Urology & Urologic Oncology, in San Antonio, is convinced that this is a far better choice than surgery for most men with prostate cancer, regardless of the patient's age or tumor characteristics.

Brachytherapy Very Effective Long-Term

Jody A. Charnow March 02, 2010

Brachytherapy offers excellent oncologic outcomes and is associated with a low rate of adverse events, data show.

Adding Hormone Therapy to Brachytherapy May Raise Death Risk in Older Men

Jody A. Charnow January 11, 2010

Adding androgen deprivation therapy (ADT) to brachytherapy for localized prostate cancer may increase the risk of death among men aged 73 years and older, data suggest.